EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endothelin-1 in Health and Disease

Katherine M R M Banecki, Kim A Dora iD

International Journal of Molecular Sciences · 10.07.2023 · 24 (14) · 11295

DOI: 10.3390/ijms241411295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.07.2023. Verfasst von Katherine M R M Banecki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK. Hauptthemen laut MEDLINE: Cardiovascular Diseases, COVID-19, Endothelin-1, Chronic Pain. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Bodleian Library, University of Oxford.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Discovered almost 40 years ago, the potent vasoconstrictor peptide endothelin-1 (ET-1) has a wide range of roles both physiologically and pathologically. In recent years, there has been a focus on the contribution of ET-1 to disease. This has led to the development of various ET receptor antagonists, some of which are approved for the treatment of pulmonary arterial hypertension, while clinical trials for other diseases have been numerous yet, for the most part, unsuccessful. However, given the vast physiological impact of ET-1, it is both surprising and disappointing that therapeutics targeting the ET-1 pathway remain limited. Strategies aimed at the pathways influencing the synthesis and release of ET-1 could provide new therapeutic avenues, yet research using cultured cells in vitro has had little follow up in intact ex vivo and in vivo preparations. This article summarises what is currently known about the synthesis, storage and release of ET-1 as well as the role of ET-1 in several diseases including cardiovascular diseases, COVID-19 and chronic pain. Unravelling the ET-1 pathway and identifying therapeutic targets has the potential to treat many diseases whether through disease prevention, slowing disease progression or reversing pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCOVID-19Endothelin-1Chronic PainHumansEndothelins

Stichwörter der Autor:innen

cardiovascular diseaseendothelin-1endotheliumreleasestoragevasculature

Substanzen

Endothelin-1Endothelins

Autor:innen und Institutionen

  • Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.

ORCID-Profile: Kim A Dora

Förderung

  • British Heart Foundation
  • Bodleian Library, University of Oxford

Zitieren

APA

Banecki, K. M. R. M., & Dora, K. A. (2023). Endothelin-1 in Health and Disease. International Journal of Molecular Sciences, 24(14), 11295. https://doi.org/10.3390/ijms241411295

Vancouver

Banecki KMRM, Dora KA. Endothelin-1 in Health and Disease. International Journal of Molecular Sciences. 2023;24(14):11295. doi:10.3390/ijms241411295

BibTeX
@article{Banecki2023,
  author = {Banecki, Katherine M R M and Dora, Kim A},
  title = {Endothelin-1 in Health and Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {14},
  pages = {11295},
  doi = {10.3390/ijms241411295}
}
Kostenlos starten →